124 related articles for article (PubMed ID: 18207267)
1. 99mTc-Tetrofosmin brain SPECT in prognostic assessment of high-grade gliomas.
Alexiou GA; Tsiouris S; Polyzoidis KS; Kyritsis AP; Fotopoulos AD
Radiother Oncol; 2008 Feb; 86(2):290. PubMed ID: 18207267
[No Abstract] [Full Text] [Related]
2. Correlation of glioma proliferation assessed by flow cytometry with (99m)Tc-Tetrofosmin SPECT uptake.
Alexiou GA; Tsiouris S; Vartholomatos G; Fotakopoulos G; Papadopoulos A; Kyritsis AP; Voulgaris S; Fotopoulos AD
Clin Neurol Neurosurg; 2009 Dec; 111(10):808-11. PubMed ID: 19726126
[TBL] [Abstract][Full Text] [Related]
3. 99mTc-tetrofosmin SPECT for glioma evaluation.
Alexiou GA; Tsiouris S; Kyritsis AP; Voulgaris S; Polyzoidis KS; Fotopoulos AD
Mol Imaging Biol; 2009; 11(4):223. PubMed ID: 19326176
[No Abstract] [Full Text] [Related]
4. The value of 99mTc-tetrofosmin brain SPECT in predicting survival in patients with glioblastoma multiforme.
Alexiou GA; Tsiouris S; Kyritsis AP; Fotakopoulos G; Goussia A; Voulgaris S; Fotopoulos AD
J Nucl Med; 2010 Dec; 51(12):1923-6. PubMed ID: 21078797
[TBL] [Abstract][Full Text] [Related]
5. In Reference to Alexiou et al. (Neuro-Oncology 2008;10:104-105). Evaluation of glioma proliferation by 99mTc-Tetrofosmin.
Beauchesne P
Neuro Oncol; 2008 Aug; 10(4):643. PubMed ID: 18577563
[No Abstract] [Full Text] [Related]
6. Correlation of diffusion tensor, dynamic susceptibility contrast MRI and (99m)Tc-Tetrofosmin brain SPECT with tumour grade and Ki-67 immunohistochemistry in glioma.
Alexiou GA; Zikou A; Tsiouris S; Goussia A; Kosta P; Papadopoulos A; Voulgaris S; Kyritsis AP; Fotopoulos AD; Argyropoulou MI
Clin Neurol Neurosurg; 2014 Jan; 116():41-5. PubMed ID: 24309151
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of brain tumor recurrence by (99m)Tc-tetrofosmin SPECT: a prospective pilot study.
Alexiou GA; Fotopoulos AD; Papadopoulos A; Kyritsis AP; Polyzoidis KS; Tsiouris S
Ann Nucl Med; 2007 Jul; 21(5):293-8. PubMed ID: 17634847
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of glioma proliferation by 99mTc-Tetrofosmin.
Alexiou GA; Tsiouris S; Goussia A; Papadopoulos A; Kyritsis AP; Polyzoidis KS; Fotopoulos AD
Neuro Oncol; 2008 Feb; 10(1):104-5. PubMed ID: 18055861
[No Abstract] [Full Text] [Related]
9. Comparison between contrast-enhanced magnetic resonance imaging and technetium 99m glucohepatonic acid single photon emission computed tomography with histopathologic correlation in gliomas.
Kumar RA; Khandelwal N; Sodhi KS; Pathak A; Mittal BR; Radotra BD; Suri S
J Comput Assist Tomogr; 2006; 30(5):723-33. PubMed ID: 16954918
[TBL] [Abstract][Full Text] [Related]
10. Scintigraphic assessment of recurrent glioma with focus on proliferation.
Alexiou GA; Tsiouris S; Polyzoidis KS; Kyritsis AP; Fotopoulos AD
Nucl Med Commun; 2008 Sep; 29(9):840-1. PubMed ID: 18677216
[No Abstract] [Full Text] [Related]
11. Radiologic diagnosis, staging, and follow-up of adult central nervous system primary malignant glioma.
Madison MT; Hall WA; Latchaw RE; Loes DJ
Radiol Clin North Am; 1994 Jan; 32(1):183-96. PubMed ID: 8284358
[TBL] [Abstract][Full Text] [Related]
12. Discrimination between glioma recurrence and radiation-induced necrosis: in regards to Qing-Shi et al. (Int J Radiat Oncol Biol Phys 2007;68:151-158).
Alexiou GA; Tsiouris S; Kyritsis AP; Polyzoidis KS; Fotopoulos AD
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1585-6; author reply 1586. PubMed ID: 17674998
[No Abstract] [Full Text] [Related]
13. 99mTc-tetrofosmin SPECT for the evaluation of cerebral lesions.
Alexiou GA; Fotopoulos AD; Tsiouris S; Voulgaris S; Kyritsis AP
Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2403-4. PubMed ID: 20821207
[No Abstract] [Full Text] [Related]
14. Evaluation of single photon emission computerised tomography (SPECT) using Tc99m-tetrofosmin as a diagnostic modality for recurrent posterior fossa tumours.
Barai S; Bandopadhayaya GP; Julka PK; Haloi AK; Seith A; Malhotra A
J Postgrad Med; 2003; 49(4):316-20; discussion 320-1. PubMed ID: 14699229
[TBL] [Abstract][Full Text] [Related]
15. The role of 99mTc-tetrofosmin brain SPECT in differentiating treatment-induced necrosis from recurrent brain tumor.
Alexiou GA; Fotopoulos AD; Tsiouris S; Voulgaris S; Kyritsis AP
J Neurooncol; 2011 Sep; 104(2):611. PubMed ID: 21188468
[No Abstract] [Full Text] [Related]
16. Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: comparison with thallium-201 imaging.
Soricelli A; Cuocolo A; Varrone A; Discepolo A; Tedeschi E; Mainenti PP; Grivet-Fojaja MR; Covelli EM; Postiglione A; Salvatore M
J Nucl Med; 1998 May; 39(5):802-6. PubMed ID: 9591579
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of SPECT/CT with a hybrid camera for the functional anatomical mapping of primary brain tumors by [Tc99m] tetrofosmin.
Filippi L; Schillaci O; Santoni R; Manni C; Danieli R; Simonetti G
Cancer Biother Radiopharm; 2006 Feb; 21(1):41-8. PubMed ID: 16480330
[TBL] [Abstract][Full Text] [Related]
18. Brain SPECT by 99mTc-tetrofosmin for the differentiation of tumor recurrence from radiation injury.
Alexiou GA; Tsiouris S; Kyritsis AP; Polyzoidis KS; Fotopoulos AD
J Nucl Med; 2008 Oct; 49(10):1733-4; author reply 1734. PubMed ID: 18794274
[No Abstract] [Full Text] [Related]
19. Characterization of intracranial space-occupying lesions by ⁹⁹(m)Tc-Tetrofosmin SPECT.
Fotopoulos AD; Kyritsis AP; Tsiouris S; Al-Boucharali J; Papadopoulos A; Voulgaris S; Alexiou GA
J Neurooncol; 2011 Jan; 101(1):83-9. PubMed ID: 20496160
[TBL] [Abstract][Full Text] [Related]
20. Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy.
Schwartz RB; Holman BL; Polak JF; Garada BM; Schwartz MS; Folkerth R; Carvalho PA; Loeffler JS; Shrieve DC; Black PM; Alexander E
J Neurosurg; 1998 Jul; 89(1):60-8. PubMed ID: 9647173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
